Literature DB >> 24634483

Thoracotomy and decortication: impact of culture-positive empyema on the outcome of surgery.

Lawrence Okiror1, Cordelia Coltart2, Andrea Bille3, Lucy Guile2, John Pilling4, Karen Harrison-Phipps4, Tom Routledge4, Loic Lang-Lazdunski4, Carolyn Hemsley2, Juliet King4.   

Abstract

OBJECTIVES: This study aimed to assess the efficacy of thoracotomy and decortication (T/D) in achieving lung re-expansion in patients with Stage III empyema and assess the impact of culture-positive empyema on the outcome of decortication.
METHODS: This is a retrospective observational study of consecutive patients treated with T/D over a 6-year period.
RESULTS: A total of 107 consecutive patients were identified. The median age was 55 (range 16-86) years; of which, 86% were male. The median length of hospital stay was 9 (range 2-45) days. Full lung re-expansion was achieved in 86% of cases. There were no postoperative deaths. Pleural cultures were positive in 56 (52%) cases. Patients with culture-positive empyema had a longer duration of pleural drainage (median of 11 days, range 3-112 versus median of 5 days, range 3-29 days for negative culture; P = 0.0004), longer length of hospital stay (median of 11 days, range 4-45 versus median of 7 days, range 2-34 days; P = 0.0002) and more complications (P = 0.0008), respectively. There was no statistically significant difference in the outcome of surgery, i.e. lung re-expansion versus trapped lung (P = 0.08) between the two groups.
CONCLUSIONS: T/D is safe and achieved lung re-expansion in the majority of patients. Culture-positive empyema was associated with worse outcomes.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Bacterial culture; Stage III empyema; Thoracotomy and decortication

Mesh:

Year:  2014        PMID: 24634483     DOI: 10.1093/ejcts/ezu104

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Procalcitonin as preoperative marker for surgery in advanced parapneumonic empyema.

Authors:  Claudio Caviezel; Philipp Schuetz; Stephan Gerdes; Franco Gambazzi
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  A systematic review of comorbidities and outcomes of adult patients with pleural infection.

Authors:  Tamsin N Cargill; Maged Hassan; John P Corcoran; Elinor Harriss; Rachelle Asciak; Rachel M Mercer; David J McCracken; Eihab O Bedawi; Najib M Rahman
Journal:  Eur Respir J       Date:  2019-10-01       Impact factor: 16.671

3.  Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea.

Authors:  Cheol-Kyu Park; Hyoung-Joo Oh; Ha-Young Choi; Hong-Joon Shin; Jung Hwan Lim; In-Jae Oh; Yu-Il Kim; Sung-Chul Lim; Young-Chul Kim; Yong-Soo Kwon
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

Review 4.  Diagnostic Accuracy of Imaging Findings in Pleural Empyema: Systematic Review and Meta-Analysis.

Authors:  Desiree Zettinig; Tugba Akinci D'Antonoli; Adrian Wilder-Smith; Jens Bremerich; Jan A Roth; Raphael Sexauer
Journal:  J Imaging       Date:  2021-12-28

5.  Considerations on Baseline Generation for Imaging AI Studies Illustrated on the CT-Based Prediction of Empyema and Outcome Assessment.

Authors:  Raphael Sexauer; Bram Stieltjes; Jens Bremerich; Tugba Akinci D'Antonoli; Noemi Schmidt
Journal:  J Imaging       Date:  2022-02-22

6.  Assessment of Intraoperative Microbiological Culture in Patients with Empyema: Comparison with Preoperative Microbiological Culture.

Authors:  Takaki Akamine; Hirokazu Kitahara; Asato Hashinokuchi; Mototsugu Shimokawa; Naoko Miura; Takuro Kometani; Yasunori Shikada; Takashi Sonoda
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-05-08       Impact factor: 1.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.